Improving Birth Outcomes with Technology and Education The BETTER Program for Pregnant Women
Led by Ohio State University · Updated on 2026-06-09
550
Participants Needed
3
Research Sites
26 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are evaluating the BETTER intervention compared to standard obstetrical care to see if it can reduce maternal anemia and other negative pregnancy outcomes. This study focuses on pregnant patients receiving care at two clinics and aims to improve understanding of how addressing social needs through technology and education can affect maternal and child health. It is a pragmatic randomized control trial involving 550 participants.
The BETTER intervention involves one motivational interviewing session soon after randomization, encouraging patients to address social needs such as housing, food, and transportation. After that, patients receive bi-weekly text messages with links to resources including a patient portal, a local support organization, and a nationwide resource website. The control group receives standard care without motivational interviewing or text messages.
Participants will provide baseline information during a prenatal appointment before 20 weeks of pregnancy and again between 28 and 32 weeks gestation. Data collection continues after delivery, using surveys and electronic health records to assess outcomes like maternal anemia at delivery and other pregnancy complications through about six months postpartum. The study tracks maternal and infant health, including preterm birth, hypertensive disorders, infections, and hospital readmissions.
CONDITIONS
Brief Title
Better Birth Outcomes Through Technology, Education, and Reporting
Research Team
A
Ann McAlearney, ScD, MS
N
Nicole Thomas, PhD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match. Sign up to get personalized trial recommendations delivered to your inbox.
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
Factors
BETTER intervention
Standard care
Antenatal multiple micronutrients
What it is
A behavioral support approach combining a motivational interviewing session plus regular text messages linking pregnant individuals to social service resources
Routine obstetric care without motivational interviewing or text message–based social support
Routine antenatal multiple micronutrient supplementation including iron and folic acid is an established preventive practice for maternal anemia during pregnancy
Role in the trial
Participants receive the investigational BETTER behavioral support intervention
Participants receive standard obstetric care without additional behavioral support
Represents routine preventive care offered in many antenatal settings, not part of the trial
Primary use
To help reduce maternal anemia and improve birth and pregnancy outcomes by addressing social needs via motivational interviewing and messaging
Serves as the control condition, reflecting usual obstetric care without additional messaging support
Prevention of maternal anemia through daily or routine micronutrient supplementation including iron and folic acid
How it is given or performed
Delivered via one motivational interviewing session and recurring text messages linking to social resources
Usual obstetric care without additional behavioral intervention or messaging
Provided as daily or routine micronutrient supplements during antenatal visits
Evidence status
Effectiveness is being studied; outcomes not yet available from this trial
Represents current practice with no new efficacy data in this trial
Has demonstrated benefit in reducing maternal anemia and improving birth outcomes in multiple guideline-supported studies
Important risks
Not yet established; behavioral intervention generally low-risk but trial results pending
No additional risks beyond usual obstetric care
Micronutrient supplementation is generally safe when dosed appropriately during pregnancy
Important limitations
Intervention addresses social needs but does not include nutrient supplementation; effectiveness for anemia prevention unproven yet
Does not include additional behavioral or messaging support to address social determinants of anemia risk
Micronutrient supplementation may not address social needs or barriers to care that affect anemia risk
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
Who Can Participate
Age: 18Years +
FEMALE
Eligibility Criteria
You may qualify if you...
Less than 20 weeks and 6 days pregnant upon enrollment
At least 18 years of age
Receiving obstetric care at OSU McCampbell Hall or OSU Outpatient Care East
Singleton pregnancy and fetus with a heartbeat
English speaking
Able to receive text messages
You will not qualify if you...
Has a significant medical condition (eg sickle cell disease) that is a cause of anemia
Has a plan for transfusion during pregnancy
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Enrollment and Baseline Data Collection
Duration - Up to 1 visit
At the prenatal appointment before 21 weeks, participants are randomly assigned to the intervention or control group and provide baseline information including demographics and patient-reported outcomes.
1 visit (in-person)
Intervention Period
Duration - From enrollment until delivery (up to about 6 months)
Participants in the intervention group receive one motivational interviewing session and bi-weekly text messages until delivery. Control group participants receive standard care without these supports.
Visits during routine prenatal care
Follow-up and Outcome Assessment
Duration - Up to 6 months post-delivery
After delivery, research staff collect medical record data and survey responses to assess maternal anemia and other pregnancy outcomes up to about six months postpartum.
Data collection from medical records and surveys
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
2
Similar Trials
Evaluating Universal Versus Point-of-Care Antiviral Treatment to Prevent Mother-to-Child Transmission of Hepatitis B in Pregnant Women
Prediction Model Study for Pregnancy Outcomes in Women Affected by Aplastic Anemia
Repository Study to Collect and Analyze Human Microbiome Samples
for Understanding Health and Disease Interactions
Validating the Enlighten Device to Predict Postpartum Depression Using At-Home Blood and Saliva Samples in Pregnant Women
Observing Health and Experiences of Females with Cystic Fibrosis During Pregnancy and Early Parenthood, and Follow-up of Their Children
Evaluating Digital Support and Packaging Effects on Multiple Micronutrient Supplement Use Among Pregnant Women in Lombok Island
Advanced Fetal Imaging Study Using New MRI Technology for Pregnant Women
Testing Specialized MRI Coils and Techniques to Improve Fetal Imaging Quality
Study to Evaluate the Accuracy of the T-ACE Self-report for Detecting High-Risk Alcohol Use During Pregnancy Compared to a Blood Test
Study of an Agricultural Support Program to Improve Health and Nutrition for Pregnant Women and Their Babies in Kenya
Evaluating an Online Intuitive Eating Program to Support Well-Being and Manage Weight Gain in Pregnant Women with Obesity
Have more questions? Get in touch with our team for quick support
Published Research Related To This Trial
Patient-informed outpatient intervention to improve pregnancy outcomes through connections to social services: protocol for the BETTER randomised controlled trial.
Ann Scheck McAlearney, Sarah R MacEwan, Timothy R Huerta...